Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Rabkin, Samuel D  [Clear All Filters]
2024
Bommareddy PK, Wakimoto H, Martuza RL, Kaufman HL, Rabkin SD, Saha D. Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. J Immunother Cancer. 2024;12(4).
2023
Kardani K, Gil JSanchez, Rabkin SD. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells. Front Cell Infect Microbiol. 2023;13:1206111.
2019
Tanaka S, Luk S, Kiyokawa J, Onozato ML, A Iafrate J, Shah K, Martuza RL, Rabkin SD, Batchelor TT, Cahill DP, et al. Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy. Sci Rep. 2019;9(1):139.
Wu M-R, Nissim L, Stupp D, Pery E, Binder-Nissim A, Weisinger K, Enghuus C, Palacios SR, Humphrey M, Zhang Z, et al. A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS). Nat Commun. 2019;10(1):2880.
2015
Nigim F, Cavanaugh J, Patel AP, Curry WT, Esaki S-I, Kasper EM, Chi AS, Louis DN, Martuza RL, Rabkin SD, et al. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment. J Neuropathol Exp Neurol. 2015;74(7):710-722.
2014
Cheema TA, Fecci PE, Ning J, Rabkin SD. Immunovirotherapy for the treatment of glioblastoma. Oncoimmunology. 2014;3(1):e27218.
Antoszczyk S, Spyra M, Mautner VFelix, Kurtz A, Stemmer-Rachamimov AO, Martuza RL, Rabkin SD. Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus. Neuro Oncol. 2014.
2013
Cheema TA, Wakimoto H, Fecci PE, Ning J, Kuroda T, Jeyaretna DS, Martuza RL, Rabkin SD. Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model. Proc Natl Acad Sci U S A. 2013.